TALK Q4 2025 Earnings Call Summary | Stock Taper
Logo
TALK

TALK — Talkspace, Inc.

NASDAQ


Q4 2025 Earnings Call Summary

February 19, 2026

Talkspace Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

  • Q4 Revenue: $63.0 million, a 29.3% year-over-year increase.
  • Payor Revenue: $47.7 million, up 41% year-over-year, driven by increased session volume (450,000 sessions, a 36.3% increase).
  • Unique Active Payor Members: 124,000, representing a 29.7% year-over-year increase.
  • Direct-to-Enterprise Revenue: $11.6 million, up 21.8% year-over-year.
  • Consumer Revenue: $3.7 million, consistent with strategic focus on Payor and Enterprise channels.
  • Gross Profit: $26.9 million, a gross margin of 42.7%.
  • Operating Expenses: $23.1 million, improved as a percentage of revenue to 36.7%.
  • Adjusted EBITDA: $6.6 million, a 147.1% year-over-year growth with a margin of 10.4%.
  • Full Year Revenue: Approximately $229 million, a 22% increase year-over-year, with adjusted EBITDA growing from $7 million in 2024 to $15.8 million in 2025 (7% margin).

2. Strategic Updates and Business Highlights:

  • Transition from a Consumer model to a Payor fee-for-service model has been successful, with Payor sessions growing at an annualized rate of 56%.
  • Expanded partnerships with Payors have improved patient experience, including directory integrations and scheduling capabilities.
  • Acquisition of Wisdo, an AI-powered social health platform, has enhanced offerings in the Medicare space.
  • Youth programs (Teenspace) have shown strong engagement, with over 45,000 teens enrolled in NYC, and 66% showing clinical improvement.
  • Continued investment in AI initiatives, including the development of the TalkAI agent designed for mental health support, which is currently in beta testing.

3. Forward Guidance and Outlook:

  • 2026 Revenue Guidance: Expected to be between $275 million and $290 million, representing 20% to 27% year-over-year growth.
  • Adjusted EBITDA Guidance: Anticipated to be between $30 million and $35 million, indicating growth of 90% to 122%.
  • The company expects to maintain strong momentum in the Payor business and improve profitability, targeting EBITDA margins in the mid-teens by the end of 2026.

4. Bad News, Challenges, or Points of Concern:

  • Consumer revenue is intentionally declining as the company shifts focus to Payor and Enterprise channels, which may impact overall revenue diversity.
  • The competitive landscape for mental health services is evolving rapidly, particularly with the rise of AI-driven solutions, which may pose challenges in user acquisition and retention.
  • There are uncertainties regarding the impact of rising healthcare costs on Payor relationships and potential reimbursement changes.
  • The need for ongoing investment in marketing and technology to maintain competitive advantage in the AI space.

5. Notable Q&A Insights:

  • Management acknowledged the challenges of transitioning users from general-purpose AI models to their specialized TalkAI agent, emphasizing the importance of user privacy and security.
  • Discussions around the Medicare Advantage (MA) market highlighted the company's commitment to participating in new access programs, which could enhance their Medicare efforts.
  • The integration of directory services with Payors is expected to expand, with at least three additional integrations planned for early 2026.
  • Management expressed confidence in their provider network's adequacy but noted the need for ongoing engagement and potential growth in specific areas, particularly psychiatry.
  • The company is not currently pursuing additional acquisitions but remains open to tuck-in opportunities if they align with strategic goals.